Impact Biomedical IBO
NYSE IBO
$3.80 -0.22 (-5.47%)
As of: Oct 22, 2026 · 3:58 PM EDT

Impact Biomedical (IBO) EBITDA (2022 - 2026)

Updated

Impact Biomedical's EBITDA was -$418,000 in Q2 2026, compared with -$865,000 a year earlier.

Analysis

Impact Biomedical (IBO) EBITDA (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Impact Biomedical's EBITDA was -$3.95 million through Jun 30, 2026; for FY2024, it came in at -$27.63 million.

  • In earlier years, EBITDA was -$2.91 million in FY2023 and -$2.29 million in FY2022.
  • The Q2 2026 figure marks the highest quarterly EBITDA since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 8.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 8.33 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 5.09 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -9.70 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 5.89 Bn
10 Impact Biomedical 428.05 Mn 428.01 Mn 2,000.00 -418,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -418,000.00
Mar 31, 2026 -2.00 Mn
Sep 30, 2025 -660,000.00
Jun 30, 2025 -865,000.00
Mar 31, 2025 -727,000.00
Dec 31, 2024 -25.95 Mn
Sep 30, 2024 -846,000.00
Jun 30, 2024 -347,000.00
Mar 31, 2024 -491,000.00
Dec 31, 2023 -859,000.00
Sep 30, 2023 -798,000.00
Jun 30, 2023 -728,000.00
Mar 31, 2023 -523,000.00
Dec 31, 2022 -754,000.00
Sep 30, 2022 -610,000.00
Jun 30, 2022 -472,000.00
API Access

Impact Biomedical EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=IBO&period=max&api_key=YOUR_API_KEY